Agios Pharmaceuticals, Inc.AGIONASDAQ
Loading
Year-over-year earnings per share growth rate
Percentile
P49
Within normal range
vs 5Y Ago
-2.8x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -3.93% |
| Q3 2025 | 7.77% |
| Q2 2025 | -24.52% |
| Q1 2025 | 8.28% |
| Q4 2024 | -110.15% |
| Q3 2024 | 1085.21% |
| Q2 2024 | -16.55% |
| Q1 2024 | 15.70% |
| Q4 2023 | -4.88% |
| Q3 2023 | -8.61% |
| Q2 2023 | -16.15% |
| Q1 2023 | -141.40% |
| Q4 2022 | 337.88% |
| Q3 2022 | 21.43% |
| Q2 2022 | -3.70% |
| Q1 2022 | 6.90% |
| Q4 2021 | -11.54% |
| Q3 2021 | -10.64% |
| Q2 2021 | -105.23% |
| Q1 2021 | 2011.35% |
| Q4 2020 | 1.40% |
| Q3 2020 | -9.16% |
| Q2 2020 | -122.03% |
| Q1 2020 | 63.13% |
| Q4 2019 | 11.60% |
| Q3 2019 | 3.21% |
| Q2 2019 | -17.61% |
| Q1 2019 | -0.63% |
| Q4 2018 | 3.07% |
| Q3 2018 | -36.97% |
| Q2 2018 | 26.99% |
| Q1 2018 | 9.94% |
| Q4 2017 | -13.84% |
| Q3 2017 | 10.67% |
| Q2 2017 | -14.10% |
| Q1 2017 | -16.42% |
| Q4 2016 | 17.79% |
| Q3 2016 | -10.88% |
| Q2 2016 | -140.98% |
| Q1 2016 | 43.52% |